InvestorsHub Logo
Followers 3418
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: Clem326 post# 66467

Wednesday, 03/27/2013 9:04:07 PM

Wednesday, March 27, 2013 9:04:07 PM

Post# of 97239
RPRX..$9.13..Repros Reports Both Primary Endpoints Successfully Met in First Pivotal Study of Androxal. Conference Call tomorrow morning! http://yhoo.it/16Z9DCv

Sheff's Station...All Aboard...Sign Up Here!

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.